PL2285387T3 - Odżywka do zapobiegania infekcjom - Google Patents

Odżywka do zapobiegania infekcjom

Info

Publication number
PL2285387T3
PL2285387T3 PL09762710T PL09762710T PL2285387T3 PL 2285387 T3 PL2285387 T3 PL 2285387T3 PL 09762710 T PL09762710 T PL 09762710T PL 09762710 T PL09762710 T PL 09762710T PL 2285387 T3 PL2285387 T3 PL 2285387T3
Authority
PL
Poland
Prior art keywords
nutrition
infections
prevention
Prior art date
Application number
PL09762710T
Other languages
English (en)
Inventor
Jan Knol
Limpt Cornelus Johannes Petrus Van
Croix Francis Le
Valérie Petay
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/NL2008/050375 external-priority patent/WO2009151315A1/en
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of PL2285387T3 publication Critical patent/PL2285387T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/017—Hydrolysed proteins; Derivatives thereof from animals from blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pulmonology (AREA)
  • Pediatric Medicine (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL09762710T 2008-06-13 2009-06-12 Odżywka do zapobiegania infekcjom PL2285387T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/NL2008/050375 WO2009151315A1 (en) 2008-06-13 2008-06-13 Nutritional composition for infants delivered via caesarean section
EP08168054 2008-10-31
EP09762710.3A EP2285387B1 (en) 2008-06-13 2009-06-12 Nutrition for prevention of infections
PCT/NL2009/050330 WO2009151329A1 (en) 2008-06-13 2009-06-12 Nutrition for prevention of infections

Publications (1)

Publication Number Publication Date
PL2285387T3 true PL2285387T3 (pl) 2016-03-31

Family

ID=40935729

Family Applications (2)

Application Number Title Priority Date Filing Date
PL09762711T PL2293677T3 (pl) 2008-06-13 2009-06-12 Kompozycja żywieniowa dla niemowląt urodzonych poprzez cięcie cesarskie
PL09762710T PL2285387T3 (pl) 2008-06-13 2009-06-12 Odżywka do zapobiegania infekcjom

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL09762711T PL2293677T3 (pl) 2008-06-13 2009-06-12 Kompozycja żywieniowa dla niemowląt urodzonych poprzez cięcie cesarskie

Country Status (13)

Country Link
US (5) US20110097437A1 (pl)
EP (4) EP3326633A1 (pl)
CN (3) CN102123715B8 (pl)
AR (3) AR072141A1 (pl)
BR (1) BRPI0915149B1 (pl)
DK (1) DK2285387T3 (pl)
ES (2) ES2656776T3 (pl)
HU (1) HUE028390T2 (pl)
PL (2) PL2293677T3 (pl)
PT (1) PT2285387E (pl)
RU (2) RU2543634C2 (pl)
SI (1) SI2285387T1 (pl)
WO (3) WO2009151331A1 (pl)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2356992B1 (en) * 2007-12-07 2017-08-16 N.V. Nutricia Bifidobactrium for dust mite allergy
ES2656776T3 (es) * 2008-06-13 2018-02-28 N.V. Nutricia Composición nutricional para bebés nacidos por cesárea
US8784798B2 (en) 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
EP2552464B1 (en) * 2010-03-30 2018-02-28 Assistance Publique - Hôpitaux de Paris Use of bifidobacteria for preventing allergy in breastfed infants
WO2011148221A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Lactic acid bacteria for maturation of the enteric nervous system in infants
WO2011150949A1 (en) * 2010-06-04 2011-12-08 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
EP3097791B1 (en) * 2010-06-04 2018-05-16 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
EP2586448B1 (en) * 2010-06-28 2018-02-07 Kabushiki Kaisha Yakult Honsha Skin properties improving agent for oral administration
WO2012057636A1 (en) * 2010-10-27 2012-05-03 Fonterra Corporate Research And Development Limited Modulation of th1 and th2 immune response by lactic acid whey
EP2449891A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
AU2011328041A1 (en) * 2010-11-11 2013-05-23 Nestec S.A. Spoonable yogurt preparations containing non-replicating probiotic micro-organisms
CN103209596A (zh) * 2010-11-11 2013-07-17 雀巢产品技术援助有限公司 含有益生微生物的冷冻糖食
EP2465508A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
WO2012078030A1 (en) * 2010-12-06 2012-06-14 N.V. Nutricia Fermented infant formula
EP2520181A1 (en) * 2011-05-02 2012-11-07 N.V. Nutricia Fermented infant formula
CN107890097A (zh) * 2010-12-06 2018-04-10 N·V·努特里奇亚 发酵的婴儿配方物
WO2012078032A1 (en) 2010-12-10 2012-06-14 N.V. Nutricia Early stimulation of taste and/or flavour acceptance
US11337990B2 (en) * 2010-12-31 2022-05-24 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
PL2481299T3 (pl) * 2011-01-31 2017-09-29 Synformulas Gmbh Szczepy bifidobacterium bifidum do stosowania w chorobach przewodu pokarmowego
DK2734210T3 (en) 2011-07-22 2018-01-22 Abbott Lab GALACTOOLIGOSACCHARIDES FOR THE PREVENTION OF DAMAGE TO AND / OR PROMOTION OF HEALING OF THE MAVE GAS CHANNEL
WO2013053073A1 (zh) * 2011-10-10 2013-04-18 Huang Daiyong 一种基于甘露寡糖的胃肠道健康因子组合物
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
WO2014070016A2 (en) * 2012-11-02 2014-05-08 N.V. Nutricia Synbiotics combination for brain improvement
WO2014134281A1 (en) 2013-02-28 2014-09-04 Full Spectrum Laboratories Limited Biosynthesis of cannabinoids
US9352020B2 (en) * 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US20140271978A1 (en) * 2013-03-15 2014-09-18 Mead Johnson Nutrition Company Low-buffer nutritional compositions and uses thereof
PL2986157T3 (pl) * 2013-04-08 2020-07-27 N.V. Nutricia Fermentowana kompozycja odżywcza z inhibitorem proteazy tiolowej
WO2014200334A1 (en) * 2013-06-14 2014-12-18 N.V. Nutricia Synbiotic composition for treatment of infections in allergic patients
CN104413334A (zh) * 2013-08-30 2015-03-18 深圳华大基因科技有限公司 可食用组合物及其制备方法和用途
EP2857410A1 (en) 2013-10-04 2015-04-08 Jennewein Biotechnologie GmbH Process for purification of 2´-fucosyllactose using simulated moving bed chromatography
RU2663065C2 (ru) 2013-11-04 2018-08-01 Н.В. Нютрисиа Ферментированное детское питание с неперевариваемыми олигосахаридами
CN105722515A (zh) 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗有风险婴儿或幼儿的urt感染的组合物
RU2016129426A (ru) * 2013-12-19 2018-01-24 Нестек С.А. Питательная композиция для снижения метаболического стресса у младенцев
US9394510B2 (en) 2014-08-25 2016-07-19 Full Spectrum Laboratories Limited Apparatus and methods for the simultaneous production of compounds
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
WO2017043962A1 (en) * 2015-09-11 2017-03-16 N.V. Nutricia Method for stimulating microbiota health after non-natural birth
EP3150257A1 (en) * 2015-09-30 2017-04-05 Buga, Doris A method for producing a composition for strengthening the immune system
CN105341938B (zh) * 2015-10-10 2018-06-26 北京康比特体育科技股份有限公司 一种降低大强度运动后呼吸道感染率的保健食品
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
CN108697141A (zh) * 2015-12-29 2018-10-23 N·V·努特里奇亚 含有不可消化寡糖和非复制型产乳酸细菌的营养配方物
EP3397076A1 (en) * 2015-12-29 2018-11-07 N.V. Nutricia Fermented formula with non-digestible oligosaccharides
EP3454674B1 (en) 2016-05-10 2020-12-02 N.V. Nutricia Methods of use of fermented infant formula
EP3454672B1 (en) 2016-05-10 2020-07-01 N.V. Nutricia Uses of fermented infant formula
JP6873234B2 (ja) * 2016-09-30 2021-05-19 ズィ・エイツー・ミルク・カンパニー・リミテッド ベータカゼイン類および腸微生物叢
CN110573164B (zh) * 2017-03-08 2023-09-29 N·V·努特里奇亚 用于减轻鼻上皮炎症的含有不可消化的低聚糖的组合物
US20200305488A1 (en) * 2017-07-07 2020-10-01 Societe Des Produitis Nestle S.A. Human milk fortifier
CN107397230A (zh) * 2017-08-21 2017-11-28 杭州特悘衡康生物科技有限公司 营养组合物、促进手术后肌肉恢复和蛋白质合成的配方食品及其应用
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
PL3723778T3 (pl) * 2017-12-11 2025-06-02 N.V. Nutricia Kompozycja do stosowania w leczeniu opóźnionej kolonizacji przez bifidobacterium po urodzeniu
CN112384227A (zh) * 2018-02-09 2021-02-19 N·V·努特里奇亚 含有不可消化寡糖的发酵配方物
CN111698993A (zh) 2018-02-09 2020-09-22 N·V·努特里奇亚 含有不可消化寡糖的发酵配方物
EP3646739A1 (en) 2018-11-01 2020-05-06 N.V. Nutricia Nutritional composition comprising urea and non-digestible oligosaccharides
CN112912088B (zh) * 2019-01-16 2024-12-24 N·V·努特里奇亚 用于轮状病毒引起的感染的具有非消化性寡糖的经发酵配方食品
CN113423288A (zh) * 2019-02-04 2021-09-21 N·V·努特里奇亚 用于睡眠改善的含有不可消化的低聚糖的发酵配方物
CN113163835A (zh) 2019-05-15 2021-07-23 N·V·努特里奇亚 促进肠道发育的发酵配方物
EP3975756A1 (en) * 2019-05-29 2022-04-06 N.V. Nutricia Non-digestible oligosaccharides for decreased colonic protein fermentation
PH12021551814A1 (en) 2019-06-04 2022-03-21 Nutricia Nv NUTRITIONAL COMPOSITION COMPRISING 2’FUCOSYLLACTOSE AND 3’GALACTOSYLLACTOSE
BR112021007254A2 (pt) 2019-06-04 2021-08-10 N.V. Nutricia composição nutricional para lactentes ou crianças de primeira infância
CN110839698A (zh) * 2019-11-29 2020-02-28 内蒙古伊利实业集团股份有限公司 一种组合物及其食品用途
GB2608587B (en) * 2021-06-25 2025-01-01 Mjn Us Holdings Llc Use of extensively hydrolysed protein
WO2024223939A1 (en) 2023-04-28 2024-10-31 Société des Produits Nestlé S.A. Compositions and methods for improving immune health
MX2025012776A (es) 2023-04-28 2026-02-03 Nestle Sa Composiciones y metodos para mejorar la salud metabolica
EP4701439A1 (en) 2023-04-28 2026-03-04 Société des Produits Nestlé S.A. Compositions and methods for improving brain health
WO2024236095A1 (en) 2023-05-16 2024-11-21 N.V. Nutricia Amino acid metabolites for enhanced detoxification activity
IL304706A (en) * 2023-07-24 2025-02-01 Mileutis Ltd Use of a preparation containing casein hydrolysate to treat inflammatory skin conditions

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110476A (en) 1977-01-10 1978-08-29 Johnson/Rhodes Cultured Foods, Inc. Preparation of liquid and frozen yogurt products
RU2031586C1 (ru) * 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
FR2723963B1 (fr) * 1994-08-31 1997-01-17 Gervais Danone Co Preparation de produits fermentes par streptococcus thermophilus, enrichis en galacto-oligosaccharides et en beta-galactosidase
EP1020123A1 (en) 1999-01-18 2000-07-19 Sitia-Yomo S.p.A. Beverages containing live lactic bacteria
FR2795917B1 (fr) 1999-07-06 2001-08-31 Gervais Danone Sa Procede de preparation d'un produit lacte immunostimulant et ses applications
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
ES2232591T3 (es) 2000-03-01 2005-06-01 Societe Des Produits Nestle S.A. Formulacion de hidratos de carbono (adyuvante prebiotico) para la mejora de la respuesta inmune.
EP1145643A1 (en) 2000-04-10 2001-10-17 Phillip Connolly Improved milk protein concentrate
US7431939B1 (en) 2000-09-28 2008-10-07 Mississippi State University Inhibition of systemic infections in humans and vertebrates by dietary fibers
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
US6953574B2 (en) * 2002-06-21 2005-10-11 Technology Commercialization, Inc. Method for producing a fermented hydrolyzed medium containing microorganisms
RU2220579C1 (ru) * 2002-07-31 2004-01-10 Зенович Сергей Михайлович Пищевой преимущественно кисломолочный продукт и закваска для его получения (варианты)
EP1549151A1 (en) * 2002-10-11 2005-07-06 Wyeth Nutritional formulations containing synbiotic substances
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
WO2004069156A2 (en) * 2003-01-30 2004-08-19 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
FR2853908B1 (fr) * 2003-04-16 2005-06-03 Gervais Danone Sa Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant
FR2857026B1 (fr) 2003-04-16 2012-11-16 Gervais Danone Sa Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant
PL1638416T3 (pl) 2003-06-23 2013-09-30 Nestec Sa Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
DK1675481T3 (da) * 2003-10-24 2009-01-19 Nutricia Nv Synbiotisk præparat til börn
DK1733730T3 (da) 2003-10-24 2008-10-13 Nutricia Nv Immunmodulerende oligosaccharider
EP1597978A1 (en) * 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
WO2006069918A1 (en) 2004-12-27 2006-07-06 Nestec S.A. Use of infant formula with reduced protein content
ES2781328T3 (es) * 2005-02-21 2020-09-01 Nestle Sa Mezcla de oligosacáridos
AU2006217160B2 (en) * 2005-02-28 2011-09-15 N.V. Nutricia Nutritional composition with probiotics
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
US20090156550A1 (en) 2005-12-06 2009-06-18 Potappel-Van T Land Belinda Composition containing oligosaccharides for the treatment/prevention of infections
WO2007081981A2 (en) 2006-01-11 2007-07-19 Attune Foods Probiotic food, process for its preparation and dietary regimen
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
ES2656776T3 (es) 2008-06-13 2018-02-28 N.V. Nutricia Composición nutricional para bebés nacidos por cesárea
WO2010008272A1 (en) 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
WO2010070613A2 (en) 2008-12-18 2010-06-24 University College London Baby feeding formula and system
WO2012078030A1 (en) 2010-12-06 2012-06-14 N.V. Nutricia Fermented infant formula
CN107890097A (zh) 2010-12-06 2018-04-10 N·V·努特里奇亚 发酵的婴儿配方物
EP2520181A1 (en) 2011-05-02 2012-11-07 N.V. Nutricia Fermented infant formula
MX389785B (es) 2011-07-26 2025-03-18 Nucitec Sa De Cv Composicion nutrimental para niños que presentan reflujo, colico y/o estreñimiento.

Also Published As

Publication number Publication date
US20110182934A1 (en) 2011-07-28
CN102123715A (zh) 2011-07-13
WO2009151330A1 (en) 2009-12-17
RU2543634C2 (ru) 2015-03-10
US20170173104A1 (en) 2017-06-22
AR078014A1 (es) 2011-10-12
BRPI0915149A2 (pt) 2015-08-04
CN102123715B8 (zh) 2026-04-14
SI2285387T1 (sl) 2016-02-29
AR072141A1 (es) 2010-08-11
ES2656776T3 (es) 2018-02-28
US20110097437A1 (en) 2011-04-28
DK2285387T3 (en) 2016-01-25
EP3326633A1 (en) 2018-05-30
RU2498605C2 (ru) 2013-11-20
EP2293803A1 (en) 2011-03-16
WO2009151331A1 (en) 2009-12-17
US10124016B2 (en) 2018-11-13
EP2293677B1 (en) 2017-11-15
PT2285387E (pt) 2016-02-09
RU2011100828A (ru) 2012-07-20
RU2011100829A (ru) 2012-07-20
EP2293677A1 (en) 2011-03-16
WO2009151329A1 (en) 2009-12-17
US20170296563A1 (en) 2017-10-19
HUE028390T2 (en) 2016-12-28
CN102118976A (zh) 2011-07-06
ES2558960T3 (es) 2016-02-09
US20110117077A1 (en) 2011-05-19
BRPI0915149B1 (pt) 2018-02-14
PL2293677T3 (pl) 2018-05-30
EP2285387A1 (en) 2011-02-23
CN102065867A (zh) 2011-05-18
AR072142A1 (es) 2010-08-11
CN102118976B (zh) 2014-02-26
EP2285387B1 (en) 2015-10-14
CN102123715B (zh) 2014-12-17

Similar Documents

Publication Publication Date Title
PL2285387T3 (pl) Odżywka do zapobiegania infekcjom
ZA200906946B (en) Inhibitors of iap
ZA201102892B (en) Pyrazolylaminopyridines as inhibitors of fak
EP2249650A4 (en) ANILINOPYRIDINE AS A FAK HEMMER
GB0814534D0 (en) Transistors
ZA201108858B (en) Iap inhibitors
IL212119A0 (en) Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
IL200499A0 (en) Stabilization of vitamin b12
PL2133419T3 (pl) Zastosowania beta-dipeptydów cyjanoficyny
GB0921986D0 (en) Video processing
DK2473482T3 (en) Methods of treating orthomyxoviral infections
ZA201004765B (en) Inhibitors of iap
GB0817926D0 (en) Articles of clothiing
ZA201108709B (en) Iap inhibitors
GB2469592B (en) Field effect transistor
GB0902648D0 (en) Pharmaceutical compounds and compositions
IL206691A (en) Sldlr for the preparation of medicines for the treatment of hepatitis @ liver
PT2306995E (pt) Propriedades antitumorais de inibidores de protease não modidficados
GB0908317D0 (en) Pharmaceutical compounds and compositions
GB0702555D0 (en) An article of footwaear
ZA201000371B (en) Article of jewelerry
GB0905525D0 (en) Compounds and uses
GB0815015D0 (en) Field effect transistors
GB0908672D0 (en) Compounds for the treatment of flaviviral infections
ZA201104003B (en) Drug for treating infections